Demographic and psychosocial factors associated with risk perception for breast cancer

Oncology Reports

Volumn 14, Issue 6, 2005, Pages 1605-1613

  Pöhls, Uwe G ^a   Fasching, Peter A ^a   Beck, Heike ^e   Kaufmann, Manfred ^c   Kiechle, Marion ^b   Von Minckwitz, Gunther ^c   Paepke, Stefan ^b   Schultz Zehden, Beate ^d   Schwarz Boeger, Ulrike ^b   Beckmann, Matthias W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e Lilly Corporate Center   (Germany)

Author keywords

Breast cancer; Psychosocial factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; BREAST TUMOR; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; FEMALE; HUMAN; MARRIAGE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AWARENESS; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MARITAL STATUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 33644697933     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.6.1605     Document Type: Article

References (46)

1. Osuch JR: Breast health and disease over a lifetime. Clin Obstet Gynecol 45: 1140-1161, 2002.
2. Beckmann MW, Fasching PA, Weiss JM, Magener A and Ortmann O: Update on primary breast cancer 2003 (update primäres Mammakarzinom 2003). Geburtsh Frauenheilk 63: R65-R92, 2003.
3. Donate F, Bollani A, Siazzi R, et al: Factors associated with non-participation of women in a breast cancer screening programme in a town in Northern Italy. J Epidemiol Community Health 45: 59-64, 1991.
4. Gil F: Hereditary breast cancer risk: factors associated with the decision to undergo BRCA1 testing. Eur Cancer Prevent 5: 488-490, 1996.
5. Lerman C, Kash K and Stefanek M: Younger women at increased risk for breast cancer: perceived risk, psychological well-being and surveillance behavior. J Natl Cancer Inst Monogr 16: 171-176, 1994.
6. Lerman C and Rimer BK: Psychosocial impact of cancer screening. Oncology 7: 67-72, 1993.
7. Gram, IT and Slenker SE: Cancer anxiety and attitudes toward mammography among screening attenders, non-attenders, and women never invited. Am J Public Health 82: 249-251, 1992.
8. Rosenstock IM: Historical origins of the health belief model. Health Educ Monogr 2: 1-8, 1974.
9. Rogers RW: A protection motivation theory of fear appeals and attitude. J Psychol 91: 93-114, 1975.
10. Weinstein ND: The precaution adoption process. Health Psychol 7: 255-286, 1988.
11. Murray M and McMillan C: Health beliefs, locus of control, emotional control and women's cancer screening behavior. Br J Clin Psychol 32: 87-100, 1993. (Pubitemid 23087727)
12. Lauver D, Nabholz S, Scott K and Tak Y: Testing theoretical explanations of mammography use. Nurs Res 46: 32-39, 1997. (Pubitemid 127457115)
13. Absetz P, Rehnberg G and Sutton SR: Comparative optimism in breast cancer risk perception: effects of experience and risk factor knowledge. Psychol Health Med 5: 367-376, 2000.
14. Facione NC, Giancarlo CA and Chan L: Seeking help for symptoms and breast cancer risk: a Chinese American perspective. Cancer Nurs 23: 258-267, 2000.
15. Facione NC and Giancarlo CA: Narratives of breast symptom discovery: implications for early detection. Cancer Nurs 21: 430-440, 1998.
16. Facione NC: Perceived risk of breast cancer: influence of heuristic thinking. Cancer Pract 10: 256-262, 2002.
17. Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med 26: 1609-1618, 1998.
18. Claus EB, Stowe M, Carter D, Holford T: The risk of a contra-lateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Breast 12: 451-456, 2003. (Pubitemid 38008659)
19. Schnitt SJ: Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 27: 836-841, 2003.
20. Collaborative Group on hormonal factors in breast cancer: Contraceptive methods and breast cancer risk: an update. Contracept Rep 11: 9-11, 2000.
21. Collaborative Group on hormonal factors in breast cancer: Breast cancer and hormonal contraceptives: collaborative analysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350: 1047-1059, 1997.
22. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A and WHI Investigators: Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women's health initiative randomized trial. JAMA 289: 3243-3253, 2003. (Pubitemid 37430077)
23. Beckmann MW, Braendle W, Brucker C, Dören M, Emons G, Geisthövel F, Kiesel L, König K, Nass-Griegoleit I, Ortmann O, Rabe T and Windler E: Hormone therapy in climactere and postmenopausal woman: a consensus of the DGGG [Konsensusempfehlungen zur Hormontherapie (HT) im Klimakterium und in der Postmenopause]. Geburtsh Frauenheilk 63: 209-212, 2003. (Pubitemid 36427211)
24. Beckmann MW, Fasching PA, Lux MP, Klemt D, Schroer B, Bodden-Heidrich R, Goecke TO, Niederacher D, Nestle-Krämling C: The familial breast cancer syndrome (das familiäre Mammakarzinom-Syndrom). Med Welt 52: 385-390, 2001. (Pubitemid 34014949)
25. Wooster R and Weber BL: Breast and ovarian cancer. N Engl J Med 348: 2339-2347, 2003. (Pubitemid 36638109)
26. Paepke S, Schubert R, Huttner C, Blohmer JU and Lichtenegger W: Awareness and preventional behaviour of the female population of Berlin and Hildesheim, Germany regarding breast cancer: results of a cross-sectional study of 2110 women (Informiertheit und Brustkrebsvorsorgeverhalten der weiblichen Bevoelkerung in Berlin und Hildesheim - Ergebnisse einer Querschnittsunter- suchung von 2110 Frauen). Geb Fra 60: 620-624, 2000. (Pubitemid 32038853)
27. Paepke S, Schwarz-Boeger U, von Minckwitz G, et al: Early Breast cancer detection (Brustkrebsfrüherkennung). Dt Aerztebl 98: 2178-2186, 2001.
28. Antoniou A, Pharoah PDP, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130, 2003. (Pubitemid 36530000)
29. Beckmann MW, Werner Y, Renner SP, Jap D and Kuschel B: Early cancer detection in gynecological practice: recent aspects of scientific discussions (Krebsfrüherkennung in der frauenärztlichen Praxis: aktuelle Aspekte der wissenschaftlichen Diskussion). Gynaekologie 30: 474-482, 2000.
30. Fylan F: Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour. Br J Gen Pract 48: 1509-1514, 1998.
31. Veronesi U, von Kleist S, Redmond K, et al: Caring about women and cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancers. Eur J Cancer 35: 1667-1675, 1999. (Pubitemid 30050638)
32. Kaufmann M and Ernst B: What women with cancer are experiencing, perceiving, knowing and missing (was Frauen mit Krebs erfahren, empfinden, wissen und vermissen). Dt Aerztebl 97: A3191-A3196, 2000.
33. Glaus A and Castiglione M: Women and cancer: result of a Swiss survey in patients with breast or gynecological cancer (Frauen und Krebs: Resultate der Umfrage bei Schweizer Patientinnen mit Brustkrebs oder einem gynäkologischen Tumor), [http://www.swisscancer.ch/cawac/editoral/index2- de.html].
34. Serin D, Pujoi H, Schraub S and Chevalier H: Parcours de femmes. Opinion survey carried out among women treated for gynecologic and breast cancers and their medical care teams. Bull Cancer 85: 578-588, 1998. (Pubitemid 28350254)
35. Paul C, Barratt A, Redman S, Cockburn, J and Lowe J: Knowledge and perceptions about breast cancer incidence, fatality and risk among Australian women. Aust NZJ Public Health 23: 396-400, 1999. (Pubitemid 29389262)
36. Freeman AG, Scott C, Waxman A and Arcona S: What do adolescent females know about breast cancer and prevention? J Pediatr Adolesc Gynecol 13: 96, 2000.
37. Metsch LR, McCoy C, McCoy HV, Pereyra M, Trapido E and Miles C: The role of the physician as an information source on mammography. Cancer Pract 6: 229-236, 1998.
38. Kuschel B, Köchli OR, Niederacher D, Müller HJ and Beckmann MW: Inherited cancer syndromes: what should the practitioner know? (Hereditäre Karzinomsyndrome in der Frauenheilkunde: was der Praktiker wissen sollte?). Schweiz Med Wochenschr 130: 362-375, 2000. (Pubitemid 30154840)
39. Kuschel B, Aba F, Lux M, Jap D, Bender HG and Beckmann MW: Breast cancer: evaluation of individual risks and prevention possibilities (Mammakarzinom: Ermittlung des individuellen Erkrankungsrisikos und Möglichkeiten der Prävention). Zeitschrift für ärztliche Fortbildung und Qualitätssicherung (ZaeFO) 94: 231-237, 2000.
40. Rutledge DN, Barsevick A, Knobf MT and Bookbinder M: Breast cancer detection: knowledge, attitudes, and behaviors of women from Pennsylvania. Oncol Nurs Forum 6: 1032-1040, 2001.
41. Coleman EA and O'Sullivan P: Racial differences in breast cancer screening among women from 65 to 74 years of age: trends from 1987-1993 and barriers to screening. J Women Aging 13: 23-39, 2001. (Pubitemid 33666141)
42. Rees CE and Bath PA: Information-seeking behaviors of women with breast cancer. Oncol Nurs Forum 5: 899-907, 2001.
43. Beckmann MW, Niederacher D, Goecke TO, Bodden-Heidrich R, Schnürch HG and Bender HG: High risk families with breast and ovary cancer (Hochrisikofamilien mit Mamma- und Ovarialkarzinomen). Dt Aerztebl 94: A161-A167, 1997.
44. Rossouw JE, Anderson GL, Prentice RL, et al: Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333, 2002. (Pubitemid 34761611)
45. Anderson GL, Limacher M, Assaf AR, et al: Women's health initiative steering committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial. JAMA 291: 1701-1712, 2004. (Pubitemid 38489892)
46. Hulley S, Furberg C, Barrett-Connor E, et al: Non-cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 288: 58-66, 2002. (Pubitemid 34705519)